Amedeo Smart

Free Medical Literature Service


 

Amedeo

Ovarian Neoplasms

  Free Subscription

Articles published in
Am J Obstet Gynecol
    June 2021
  1. MARCHAND G, Mills K, Ware K
    Reply to a question regarding ovarian cancer prevention with partial salpingectomy versus complete.
    Am J Obstet Gynecol. 2021 Jun 30. pii: S0002-9378(21)00769.
    >> Share

    May 2021
  2. SUH-BURGMANN E, Brasic N, Jha P, Hung YY, et al
    Ultrasound characteristics of early stage high-grade serous ovarian cancer.
    Am J Obstet Gynecol. 2021 May 13. pii: S0002-9378(21)00551.
    >> Share

    March 2021
  3. NAUMANN RW, Hughes BN, Brown J, Drury LK, et al
    The Impact of Opportunistic Salpingectomy on Ovarian Cancer Mortality and Healthcare Costs: A Call For Universal Insurance Coverage.
    Am J Obstet Gynecol. 2021 Mar 30. pii: S0002-9378(21)00212.
    >> Share

    February 2021
  4. HARRISON RF, Fu S, Sun CC, Zhao H, et al
    Patient cost-sharing during poly(ADP-ribose) polymerase inhibitor treatment in ovarian cancer.
    Am J Obstet Gynecol. 2021 Feb 4. pii: S0002-9378(21)00086.
    >> Share

    January 2021
  5. SCHRIJVER LH, Antoniou AC, Olsson H, Mooij TM, et al
    Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study.
    Am J Obstet Gynecol. 2021 Jan 22. pii: S0002-9378(21)00038.
    >> Share

  6. MATSUO K, Mandelbaum RS, Matsuzaki S, Klar M, et al
    Ovarian conservation for young women with early-stage low-grade endometrial cancer: A proposal for a two-step approach.
    Am J Obstet Gynecol. 2021 Jan 4. pii: S0002-9378(20)32630.
    >> Share

    December 2020
  7. MASCIULLO V, Trivellizzi N, Zannoni G, Catena U, et al
    Prognostic impact of hysteroscopic resection of endometrial atypical hyperplasia/endometrioid intraepithelial neoplasia and early-stage cancer in combination with megestrol acetate.
    Am J Obstet Gynecol. 2020 Dec 29. pii: S0002-9378(20)32627.
    >> Share

    August 2020
  8. HERMENS M, van Altena AM, van der Aa M, Bulten J, et al
    Ovarian cancer prognosis in women with endometriosis. A retrospective nationwide cohort study of 32,419 women.
    Am J Obstet Gynecol. 2020 Aug 22. pii: S0002-9378(20)30883.
    >> Share

  9. SAMIMI G, Sathyamoorthy N, Tingen CM, Mazloomdoost D, et al
    Report of NCI and NICHD-Sponsored Workshop: Gynecology and Women's Health-Benign Conditions and Cancer.
    Am J Obstet Gynecol. 2020 Aug 21. pii: S0002-9378(20)30877.
    >> Share

  10. WESTIN SN, Fellman B, Sun CC, Broaddus RR, et al
    Prospective Phase II Trial of Levonorgestrel Intrauterine Device: Non-Surgical Approach for Complex Atypical Hyperplasia and Early Endometrial Cancer.
    Am J Obstet Gynecol. 2020 Aug 14. pii: S0002-9378(20)30861.
    >> Share

  11. ALBRIGHT BB, Nasioudis D, Craig S, Moss HA, et al
    Impact of Medicaid expansion on women with gynecologic cancer: A difference-in-difference analysis.
    Am J Obstet Gynecol. 2020 Aug 7. pii: S0002-9378(20)30835.
    >> Share

    July 2020
  12. PADILLA-ISERTE P, Lago V, Tauste C, DIaz-Feijoo B, et al
    Impact of uterine manipulator on oncological outcome in endometrial cancer surgery.
    Am J Obstet Gynecol. 2020 Jul 18. pii: S0002-9378(20)30744.
    >> Share

  13. FERRARI F, Forte S, Sbalzer N, Zizioli V, et al
    Validation of an enhanced recovery after surgery protocol in gynecological surgery: an Italian randomized study.
    Am J Obstet Gynecol. 2020 Jul 8. pii: S0002-9378(20)30720.
    >> Share

    June 2020
  14. FREY MK, Ellis AE, Zeligs K, Chapman-Davis E, et al
    Impact of the COVID-19 Pandemic on Quality of Life for Women with Ovarian Cancer.
    Am J Obstet Gynecol. 2020 Jun 26. pii: S0002-9378(20)30674.
    >> Share

    May 2020
  15. VETTER MH, Smrz SA, Copeland LJ, Cohn DE, et al
    Chemotherapy directly followed by PARP inhibition as an alternative to surgery in patients with BRCA- mutated ovarian cancer - a potential management strategy in the era of COVID-19.
    Am J Obstet Gynecol. 2020 May 23. pii: S0002-9378(20)30569.
    >> Share

  16. CHAMBERS LM, Morton M, Lampert E, Yao M, et al
    Use of Prophylactic Closed Incision Negative Pressure Therapy Is Associated with Reduced Surgical Site Infections in Gynecologic Oncology Patients Undergoing Laparotomy.
    Am J Obstet Gynecol. 2020 May 14. pii: S0002-9378(20)30536.
    >> Share

  17. GUO XM, Hall EF, Mazzullo L, Djordjevic M, et al
    A low-cost approach to salpingectomy at cesarean delivery.
    Am J Obstet Gynecol. 2020;222:503.
    >> Share

    April 2020
  18. MANDELBAUM RS, Adams CL, Yoshihara K, Nusbaum DJ, et al
    The rapid adoption of opportunistic salpingectomy at the time of hysterectomy for benign gynecological disease in the United States.
    Am J Obstet Gynecol. 2020 Apr 30. pii: S0002-9378(20)30514.
    >> Share

    March 2020
  19. MILLER H, Matsuo K
    A cesarean delivery sequela: Scar rupture and tumor spill during laparoscopic hysterectomy for endometrial cancer.
    Am J Obstet Gynecol. 2020 Mar 18. pii: S0002-9378(20)30337.
    >> Share

  20. KASPERS M, Llamocca E, Quick A, Dholakia J, et al
    Black and Hispanic women are less likely than White women to receive guideline-concordant endometrial cancer treatment.
    Am J Obstet Gynecol. 2020 Mar 3. pii: S0002-9378(20)30232.
    >> Share

    February 2020
  21. HANLEY GE, Kwon JS, McAlpine JN, Huntsman DG, et al
    Examining indicators of early menopause following opportunistic salpingectomy: A cohort study from British Columbia, Canada.
    Am J Obstet Gynecol. 2020 Feb 14. pii: S0002-9378(20)30143.
    >> Share

    January 2020
  22. HERMENS M, van Altena AM, Nieboer TE, Schoot BC, et al
    Incidence of endometrioid and clear-cell ovarian cancer in histological proven endometriosis. The ENOCA population-based cohort study.
    Am J Obstet Gynecol. 2020 Jan 22. pii: S0002-9378(20)30062.
    >> Share

    November 2019
  23. GREGORI-GARCIA E, Rodriguez-Garcia V, Burgues O, Martinez J, et al
    Differential expression of Receptor Activator of Nuclear Factor Kappa B in healthy endometrium, ovarian endometrioma and endometrioid ovarian cancer.
    Am J Obstet Gynecol. 2019 Nov 22. pii: S0002-9378(19)32638.
    >> Share

  24. FACER B, Wang F, Grijalva CG, Alvarez RD, et al
    Survival Outcomes for Robotic-Assisted Laparoscopy Versus Traditional Laparoscopy in Clinical Stage I Epithelial Ovarian Cancer.
    Am J Obstet Gynecol. 2019 Nov 9. pii: S0002-9378(19)32614.
    >> Share

    September 2019
  25. LAGO V, Domingo S
    New horizons of sentinel lymph node technique in early ovarian cancer.
    Am J Obstet Gynecol. 2019 Sep 19. pii: S0002-9378(19)31125.
    >> Share

  26. UCCELLA S, Fagotti A, Scambia G
    SENTINEL NODE IN OVARIAN CANCER: A CHALLENGE TO WIN.
    Am J Obstet Gynecol. 2019 Sep 18. pii: S0002-9378(19)31122.
    >> Share

  27. CHAM S, Wen T, Friedman A, Wright JD, et al
    Fragmentation of postoperative care after surgical management of ovarian cancer at 30-days and 90-days.
    Am J Obstet Gynecol. 2019 Sep 11. pii: S0002-9378(19)31110.
    >> Share

    August 2019
  28. KLEIN DA, Mann AK, Freeman AH, Liao CI, et al
    Chemotherapy alone for patients 75 years and older with epithelial ovarian cancer - is interval cytoreductive surgery still needed?
    Am J Obstet Gynecol. 2019 Aug 14. pii: S0002-9378(19)31011.
    >> Share

  29. VETTER MH, Smith B, Benedict J, Hade EM, et al
    Preoperative predictors of endometrial cancer at time of hysterectomy for endometrial intraepithelial neoplasia or complex atypical hyperplasia.
    Am J Obstet Gynecol. 2019 Aug 8. pii: S0002-9378(19)31000.
    >> Share

    July 2019
  30. GENTRY-MAHARAJ A, Burnell M, Dilley J, Ryan A, et al
    Serum HE4 and diagnosis of ovarian cancer in postmenopausal women with adnexal masses.
    Am J Obstet Gynecol. 2019 Jul 24. pii: S0002-9378(19)30936.
    >> Share

  31. TARNEY CM, Wang G, Bateman NW, Conrads KA, et al
    Biomarker Panel for Early Detection of Endometrial Cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Am J Obstet Gynecol. 2019 Jul 4. pii: S0002-9378(19)30769.
    >> Share

    June 2019
  32. GOCKLEY A, Melamed A, Cronin A, Bookman MA, et al
    Outcomes of secondary cytoreductive surgery for patients with platinum-sensitive recurrent ovarian cancer.
    Am J Obstet Gynecol. 2019 Jun 14. pii: S0002-9378(19)30773.
    >> Share

    May 2019
  33. DAI Y, Zhang J, Ren H, Zhou X, et al
    Surgical outcomes in patients with anti-N-methyl D-aspartate receptor encephalitis with ovarian teratoma.
    Am J Obstet Gynecol. 2019 May 22. pii: S0002-9378(19)30684.
    >> Share

  34. DOLL KM, Winn A
    Assessing Endometrial Cancer Risk Among US Women: Long-Term Trends using Hysterectomy-Adjusted Analysis.
    Am J Obstet Gynecol. 2019 May 21. pii: S0002-9378(19)30682.
    >> Share

  35. UCCELLA S, Nero C, Vizza E, Vargiu V, et al
    Sentinel-Node Biopsy in Early Stage Ovarian Cancer: Preliminary Results of a Prospective Multicentre Study (SELLY).
    Am J Obstet Gynecol. 2019 May 10. pii: S0002-9378(19)30660.
    >> Share

  36. MANNING-GEIST BL, Hicks-Courant K, Gockley AA, Clark RM, et al
    A novel classification of residual disease after interval debulking surgery for advanced-stage ovarian cancer to better distinguish oncologic outcome.
    Am J Obstet Gynecol. 2019 May 10. pii: S0002-9378(19)30661.
    >> Share

  37. HOLLIS RL, Carmichael J, Meynert AM, Churchman M, et al
    Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse.
    Am J Obstet Gynecol. 2019 May 2. pii: S0002-9378(19)30620.
    >> Share

    April 2019
  38. SUIDAN RS, He W, Sun CC, Zhao H, et al
    Total and out-of-pocket costs of different primary management strategies in ovarian cancer.
    Am J Obstet Gynecol. 2019 Apr 6. pii: S0002-9378(19)30565.
    >> Share

    March 2019
  39. GIBBS J, Mei S, Economos K, Lee YC, et al
    Clinicopathologic features, incidence and survival trends of gynecologic neuroendocrine tumors; a SEER data base analysis.
    Am J Obstet Gynecol. 2019 Mar 5. pii: S0002-9378(19)30431.
    >> Share

    February 2019
  40. CHAM S, Chen L, St Clair CM, Hou JY, et al
    Development and Validation of a Risk-Calculator for Adverse Perioperative Outcomes for Women with Ovarian Cancer.
    Am J Obstet Gynecol. 2019 Feb 13. pii: S0002-9378(19)30360.
    >> Share

    January 2019
  41. VENKATESH KK, Clark LH, Stamilio DM
    Cost-effectiveness of opportunistic salpingectomy vs tubal ligation at the time of cesarean delivery.
    Am J Obstet Gynecol. 2019;220:106.
    >> Share

    December 2018
  42. OKAZAKI A, Nishi K, Kasahara K
    Pseudo-Meigs Syndrome Caused by Cancer of the Uterine Corpus.
    Am J Obstet Gynecol. 2018 Dec 7. pii: S0002-9378(18)32217.
    >> Share

    October 2018
  43. COLLINS E, Strandell A, Granasen G, Idahl A, et al
    Menopausal symptoms and surgical complications after opportunistic bilateral salpingectomy, a register-based cohort study.
    Am J Obstet Gynecol. 2018 Oct 12. pii: S0002-9378(18)30898.
    >> Share

    September 2018
  44. ACKROYD SA, Brown J, Houck K, Chu C, et al
    A preoperative risk score to predict red blood cell transfusion in patients undergoing hysterectomy for ovarian cancer.
    Am J Obstet Gynecol. 2018 Sep 18. pii: S0002-9378(18)30759.
    >> Share

    August 2018
  45. TAMAUCHI S, Kajiyama H, Yoshihara M, Ikeda Y, et al
    Reproductive outcomes of 105 malignant ovarian germ cell tumor survivors: a multicenter study.
    Am J Obstet Gynecol. 2018 Aug 4. pii: S0002-9378(18)30608.
    >> Share

    May 2018
  46. HANLEY GE, Kwon JS, Finlayson SJ, Huntsman DG, et al
    Extending the safety evidence for opportunistic salpingectomy in prevention of ovarian cancer: A cohort study from British Columbia, Canada.
    Am J Obstet Gynecol. 2018 May 28. pii: S0002-9378(18)30429.
    >> Share

  47. GEMER O, Segev Y, Helpman L, Hag-Yahia N, et al
    Is there a survival advantage in diagnosing endometrial cancer in asymptomatic postmenopausal patients? An Israeli Gynecology Oncology Group study.
    Am J Obstet Gynecol. 2018 May 21. pii: S0002-9378(18)30408.
    >> Share

    April 2018
  48. PATEL S, Legood R, Evans DG, Turnbull C, et al
    Cost effectiveness of population based BRCA1 founder mutation testing in Sephardi Jewish women.
    Am J Obstet Gynecol. 2018;218:431.
    >> Share

    March 2018
  49. ADELMAN MR, Sharp HT
    Ovarian conservation vs removal at the time of benign hysterectomy.
    Am J Obstet Gynecol. 2018;218:269-279.
    >> Share

    January 2018
  50. BOAC BM, Xiong Y, Apte SM, Wenham RM, et al
    Adherence to practice guidelines is associated with reduced referral times for patients with ovarian cancer.
    Am J Obstet Gynecol. 2018 Jan 15. pii: S0002-9378(18)30018.
    >> Share

  51. GOETSCH MF
    Management of sexuality, intimacy, and menopause symptoms after ovarian cancer.
    Am J Obstet Gynecol. 2018 Jan 4. pii: S0002-9378(18)30001.
    >> Share

    November 2017
  52. MANCHANDA R, Patel S, Antoniou AC, Levy-Lahad E, et al
    Cost-effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestry.
    Am J Obstet Gynecol. 2017;217:578.
    >> Share

    October 2017
  53. ALMASI-HASHIANI A, Ayubi E, Safiri S
    Risk of metachronous ovarian cancer after ovarian conservation in young women with stage I cervical cancer: Methodological issues.
    Am J Obstet Gynecol. 2017 Oct 17. pii: S0002-9378(17)31203.
    >> Share

  54. BISHOP EA, Java JJ, Moore KN, Spirtos NM, et al
    Surgical outcomes among elderly women with endometrial cancer treated by laparoscopic hysterectomy: A NRG/Gynecologic Oncology Group Study.
    Am J Obstet Gynecol. 2017 Oct 13. pii: S0002-9378(17)31189.
    >> Share

    August 2017
  55. RUIZ MP, Huang Y, Hou JY, Tergas AI, et al
    All-Cause Mortality in Young Women with Endometrial Cancer Receiving Progesterone Therapy.
    Am J Obstet Gynecol. 2017 Aug 24. pii: S0002-9378(17)30942.
    >> Share

    July 2017
  56. ABRAMOWICZ JS, Timmerman D
    Ovarian mass-differentiating benign from malignant. The value of the International Ovarian Tumor Analysis (IOTA) ultrasound rules.
    Am J Obstet Gynecol. 2017 Jul 20. pii: S0002-9378(17)30861.
    >> Share

  57. ANTOSH DD, High R, Brown HW, Oliphant SS, et al
    Feasibility of Prophylactic Salpingectomy During Vaginal Hysterectomy.
    Am J Obstet Gynecol. 2017 Jul 19. pii: S0002-9378(17)30859.
    >> Share

  58. MARGOLIS B, Chen L, Accordino MK, Hillyer GC, et al
    Trends in End of Life Care and Healthcare Spending in Women with Uterine Cancer.
    Am J Obstet Gynecol. 2017 Jul 11. pii: S0002-9378(17)30848.
    >> Share

    June 2017
  59. MATSUO K, Machida H, Horowitz MP, Shahzad MMK, et al
    Risk of metachronous ovarian cancer after ovarian conservation in young women with stage I cervical cancer.
    Am J Obstet Gynecol. 2017 Jun 27. pii: S0002-9378(17)30788.
    >> Share

  60. CADISH LA, Shepherd JP, Barber EL, Ridgeway B, et al
    Risks and benefits of opportunistic salpingectomy during vaginal hysterectomy : A decision analysis.
    Am J Obstet Gynecol. 2017 Jun 12. pii: S0002-9378(17)30743.
    >> Share

  61. MOULTON L, Jernigan AM, Carr C, Freeman L, et al
    Single Port Laparoscopy in Gynecologic Oncology: Seven Years of Experience at a Single Institution.
    Am J Obstet Gynecol. 2017 Jun 12. pii: S0002-9378(17)30744.
    >> Share

    May 2017
  62. PETRILLO M, Marchetti C, De Leo R, Musella A, et al
    Brca Mutational Status, Initial Disease Presentation and Clinical Outcome in High-Grade Serous Advanced Ovarian Cancer: A Multicenter Study.
    Am J Obstet Gynecol. 2017 May 23. pii: S0002-9378(17)30647.
    >> Share

    April 2017
  63. WHICKER M, Black J, Altwerger G, Menderes G, et al
    Management of Sexuality, Intimacy, and Menopause Symptoms (SIMS) in Ovarian Cancer Patients: Expert Review.
    Am J Obstet Gynecol. 2017 Apr 11. pii: S0002-9378(17)30513.
    >> Share

  64. RING KL, Garcia C, Thomas MH, Modesitt SC, et al
    Current and Future Role of Genetic Screening in Gynecologic Malignancies.
    Am J Obstet Gynecol. 2017 Apr 11. pii: S0002-9378(17)30512.
    >> Share

    March 2017
  65. CHEN PH
    The yolky thecoma.
    Am J Obstet Gynecol. 2017;216:318.
    >> Share

    February 2017
  66. MOORE RG, Plante B, Hartnett E, Mitchel J, et al
    Assessment of serum HE4 levels throughout the normal menstrual cycle.
    Am J Obstet Gynecol. 2017 Feb 22. pii: S0002-9378(17)30320.
    >> Share

    January 2017
  67. STANHISER J, Chagin K, Jelovsek JE
    A Model to Predict Risk of Blood Transfusion After Gynecologic Surgery.
    Am J Obstet Gynecol. 2017 Jan 16. pii: S0002-9378(17)30104.
    >> Share

    October 2016
  68. HANLEY GE, McAlpine JN, Pearce CL, Miller D, et al
    The performance and safety of bilateral salpingectomy for ovarian cancer prevention in the United States.
    Am J Obstet Gynecol. 2016 Oct 31. pii: S0002-9378(16)30971.
    >> Share

    July 2016
  69. BINDER PS, Peipert JF, Kallogjeri D, Brooks RA, et al
    Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patients.
    Am J Obstet Gynecol. 2016 Jul 22. pii: S0002-9378(16)30470.
    >> Share

  70. FRANCHI D, Boveri S, Radice D, Portuesi R, et al
    Ultrasonographic diagnosis and longitudinal follow-up of recurrences after conservative surgery for Borderline Ovarian tumors.
    Am J Obstet Gynecol. 2016 Jul 18. pii: S0002-9378(16)30458.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016